Philadelphia Trust Company’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Buy
18,396
+3,272
+22% +$1.43M 0.47% 44
2026
Q1
$6.97M Buy
15,124
+2,172
+17% +$1.1M 0.49% 45
2025
Q4
$7.33M Buy
+12,952
New +$6.9M 0.51% 38
2022
Q2
Sell
-8,791
Closed -$2.65M 232
2022
Q1
$2.65M Sell
8,791
-192
-2% -$56.1K 0.21% 88
2021
Q4
$3.23M Sell
8,983
-284
-3% -$97.7K 0.23% 77
2021
Q3
$3.07M Buy
9,267
+18
+0.2% +$6.04K 0.23% 76
2021
Q2
$2.83M Sell
9,249
-123
-1% -$34.5K 0.2% 85
2021
Q1
$2.31M Sell
9,372
-207
-2% -$52.1K 0.18% 91
2020
Q4
$2.61M Buy
9,579
+240
+3% +$59.6K 0.21% 81
2020
Q3
$2.21M Sell
9,339
-285
-3% -$64K 0.21% 77
2020
Q2
$1.83M Buy
+9,624
New +$1.73M 0.19% 80

Other funds holding ISRG

Philadelphia Trust Company's ISRG Position: Q2 2026 in Review

Philadelphia Trust Company increased its Intuitive Surgical (ISRG) stake by 22% in Q2 2026, buying an estimated $1.43M and bringing the position to 18,396 shares worth $7.32M. The position accounts for 0.47% of the portfolio, ranked #44.

Philadelphia Trust Company first reported a position in ISRG in Q2 2020 and has held it in 11 quarters since. The position peaked at $7.33M in Q4 2025. 2,251 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Philadelphia Trust Company held 18,396 shares of Intuitive Surgical worth $7.32M as of Q2 2026.
  • Philadelphia Trust Company bought 3,272 Intuitive Surgical shares in Q2 2026, an estimated $1.43M.
  • Intuitive Surgical made up 0.47% of Philadelphia Trust Company's portfolio in Q2 2026, its #44 holding.
  • Philadelphia Trust Company first reported a position in Intuitive Surgical in Q2 2020 and has held it in 11 quarters since.
  • Philadelphia Trust Company's Intuitive Surgical position peaked at $7.33M in Q4 2025.
  • 2,251 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.